Cogent Biosciences, Inc. · NASDAQ:COGT
Morris Arlene sold 45,510 Cogent Biosciences, Inc. shares (Form 4)
Traded Aug 27, 2026 · Filed Aug 31, 2026
On Aug 27, 2026, Morris Arlene (Director) sold 45,510 Cogent Biosciences, Inc. shares at an average US$37.12 for US$1.69M under a trading plan, leaving 0 shares. Filed Aug 31, 2026 (Form 4).
- Sold
- 45,510 shares
- Price
- US$37.12 average (US$37.09 to US$37.54)
- Value
- US$1.69M
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Common Stock | Option exercise | 41,927 | US$5.64 | 41,927 | Direct |
| Aug 27, 2026 | Common Stock | Option exercise | 3,583 | US$2.52 | 45,510 | Direct |
| Aug 27, 2026 | Common Stock | Sale | 42,349 | US$37.09 | 3,161 | Direct |
| Aug 27, 2026 | Common Stock | Sale | 3,161 | US$37.54 | 0 | Direct |
Source
Related
- Cogent Biosciences, Inc.
- Morris Arlene
- Cogent Biosciences, Inc. shareholders
- Schedule 13G/A · Deerfield Mgmt, L.P. · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Robbins Andrew R · May 21, 2026
- Schedule 13G/A · Deerfield Mgmt, L.P. · May 14, 2026